Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Leukemia

Free Subscription 24.06.2019 1 Acta Haematol 1 Am J Hematol 1 Ann Hematol 1 Biochem Biophys Res Commun 1 Blood 1 Cancer 1 Eur J Haematol 6 Leuk Lymphoma 1 Leuk Res 1 Leukemia 1 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Haematol

1. GUO Z, Chen Z, Xu Y, Zhang Y, et al
   The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients.
   Acta Haematol. 2019 Jun 18:1-7. doi: 10.1159/000500588.
   PubMed     Text format     Abstract available
   
   

   
   Am J Hematol

2. AL-SAWAF O, Bazeos A, Robrecht S, Bahlo J, et al
   Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
   Am J Hematol. 2019 Jun 20. doi: 10.1002/ajh.25561.
   PubMed     Text format     Abstract available
   
   

   
   Ann Hematol

3. YANADA M, Mori J, Aoki J, Masuko M, et al
   Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.
   Ann Hematol. 2019 Jun 15. pii: 10.1007/s00277-019-03736.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

4. WANG K, Xue Y, Peng Y, Pang X, et al
   Elastic modulus and migration capability of drug treated leukemia cells K562.
   Biochem Biophys Res Commun. 2019 Jun 13. pii: S0006-291X(19)31141.
   PubMed     Text format     Abstract available
   
   

   
   Blood

5. HE X, Zhu Y, Lin YC, Li M, et al
   PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD(+) Acute Myeloid Leukemia.
   Blood. 2019 Jun 19. pii: blood.2019001282. doi: 10.1182/blood.2019001282.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

6. SHOUVAL R, Labopin M, Gorin NC, Bomze D, et al
   Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia.
   Cancer. 2019 Jun 21. doi: 10.1002/cncr.32344.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Haematol

7. HUANG Y, Zou Y, Zheng R, Ma X, et al
   MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.
   Eur J Haematol. 2019 Jun 17. doi: 10.1111/ejh.13276.
   PubMed     Text format     Abstract available
   
   

   
   Leuk Lymphoma

8. CAO L, Koh LP, Linn YC
   Successful treatment of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation with bortezomib.
   Leuk Lymphoma. 2018 Jan 18:1-3. doi: 10.1080/10428194.2017.1421759.
   PubMed     Text format    
   
   
9. KIM B, Lee H, Kim E, Shin S, et al
   Clinical utility of targeted NGS panel with comprehensive bioinformatics analysis for patients with acute lymphoblastic leukemia.
   Leuk Lymphoma. 2019 Jun 17:1-8. doi: 10.1080/10428194.2019.1627538.
   PubMed     Text format     Abstract available
   
   
10. ASTORGUES-XERRI L, Vazquez R, Odore E, Rezai K, et al
    Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.
    Leuk Lymphoma. 2019 Jun 17:1-4. doi: 10.1080/10428194.2019.1617860.
    PubMed     Text format    
    
    
11. ACUNA-VILLAORDUNA A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, et al
    High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for staging.
    Leuk Lymphoma. 2019 Jun 17:1-5. doi: 10.1080/10428194.2019.1627543.
    PubMed     Text format     Abstract available
    
    
12. STAHL M, Tallman MS
    Antibody-based therapy in acute leukemia - beware the risks.
    Leuk Lymphoma. 2019 Jun 17:1-2. doi: 10.1080/10428194.2019.1608535.
    PubMed     Text format    
    
    
13. SHAHRABI S, Maleknia M, Tavakolifar Y, D Zayeri Z, et al
    Neutropenia and leukemia development: genetic risk factors and prognosis.
    Leuk Lymphoma. 2019 Jun 19:1-12. doi: 10.1080/10428194.2019.1630622.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Res

14. D'ARENA G, Valvano L, Vitale C, Coscia M, et al
    CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results.
    Leuk Res. 2019;83:106169.
    PubMed     Text format    
    
    

    
    Leukemia

15. BRANFORD S, Kim DDH, Apperley JF, Eide CA, et al
    Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.
    Leukemia. 2019 Jun 17. pii: 10.1038/s41375-019-0512.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

16. FISCHER K, Al-Sawaf O, Bahlo J, Fink AM, et al
    Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
    N Engl J Med. 2019;380:2225-2236.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: